Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
NCT05641961 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-07-23
Summary
This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.
Conditions
- Childhood Cancer
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Interventions
- BEHAVIORAL
-
Survivorship mobile application
Mobile phone application
- OTHER
-
Questionnaires
Questionnaires assessing cancer knowledge and system usability will be delivered to participants via Survivorship App
Sponsors & Collaborators
-
Swim Across America
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Robert Goldsby, MD · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-29
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
NCT02112916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
NCT00002768 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
NCT00002792 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
NCT00005021 ·Status: COMPLETED ·Phase: PHASE1
-
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
NCT00275015 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00004231 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma
NCT00004907 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
NCT06724237 ·Status: RECRUITING ·Phase: PHASE3
-
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
NCT03096782 ·Status: COMPLETED ·Phase: PHASE2
-
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
NCT01871766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
NCT00004174 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
NCT00345865 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
NCT01025089 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia
NCT00245115 ·Status: TERMINATED ·Phase: PHASE1
-
Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
NCT00025324 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00027547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
NCT00536601 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
NCT00299780 ·Status: COMPLETED ·Phase: PHASE1
-
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
NCT00669812 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
NCT00004905 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission
NCT00002567 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
NCT00006126 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
NCT05312411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
NCT00002502 ·Status: COMPLETED ·Phase: PHASE2